Quanterix Corporation
QTRX

$472.83 M
Marketcap
$12.32
Share price
Country
$-0.05
Change (1 day)
$29.70
Year High
$10.50
Year Low
Categories

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

marketcap

Revenue of Quanterix Corporation (QTRX)

Revenue in 2023 (TTM): $121.14 M

According to Quanterix Corporation's latest financial reports the company's current revenue (TTM) is $121.14 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Quanterix Corporation

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $121.14 M $69.42 M $-38,248,000 $-31,615,000 $-32,334,000
2022 $104.95 M $46.24 M $-43,010,000 $-96,635,000 $-96,700,000
2021 $110.56 M $61.73 M $-58,586,000 $-57,724,000 $-57,688,000
2020 $86.38 M $48.18 M $-31,584,000 $-31,906,000 $-31,530,000
2019 $56.73 M $26.84 M $-41,610,000 $-40,983,000 $-40,796,000
2018 $37.63 M $17.98 M $-31,091,000 $-31,045,000 $-31,045,000
2017 $22.87 M $9.99 M $-26,067,000 $-27,019,000 $-27,019,000
2016 $17.59 M $7.75 M $-21,431,000 $-23,173,000 $-23,173,000
2015 $12.18 M $5.72 M $-14,478,000 $-15,943,000 $-15,943,000